Diagnostic Criteria for Ventilator-Associated Pneumonia (VAP)

Core Definition and Timing

VAP is defined as pneumonia occurring more than 48 hours after patients have been intubated and received mechanical ventilation, requiring a new or persistent radiographic infiltrate plus at least two clinical criteria: temperature >38°C or <36°C, leukocyte count >10,000 or <5,000 cells/ml, purulent tracheal secretions, or worsening gas exchange, as recommended by the American Thoracic Society 1, 2, 3
The 48-hour threshold distinguishes VAP from pneumonia present on admission, with a strength of evidence level of moderate 1

The American College of Chest Physicians recommends that a new and persistent (48-hour) or progressive radiographic infiltrate, plus two or more of the following clinical criteria, be used to suspect VAP: temperature >38°C or <36°C, leukocyte count >10,000 cells/ml or <5,000 cells/ml, purulent tracheal secretions, or gas exchange degradation, with a sensitivity of 69% and specificity of 75% 2, 3, 4, 5
Requiring all three clinical variables decreases sensitivity to only 23%, while using a single variable decreases specificity to 33%, highlighting the importance of combining clinical criteria for accurate diagnosis 1, 2, 3

A new or progressive infiltrate on chest radiograph is required for diagnosis, with the American College of Radiology recommending the use of chest radiographs to confirm the presence of a new infiltrate 1, 2, 6
Portable chest radiographs have only 27-35% specificity for pneumonia due to multiple mimics, emphasizing the need for careful interpretation of radiographic findings 7, 8, 5

Microbiologic analysis of respiratory secretions is required as part of the diagnostic workup, with the Infectious Diseases Society of America recommending the use of quantitative or semiquantitative cultures to guide antibiotic therapy 1, 2, 3
Gram stain and culture results guide antibiotic therapy but should not delay empiric treatment, highlighting the importance of prompt initiation of therapy 1

Patients with ARDS require heightened suspicion, with the American Thoracic Society recommending a lower threshold for diagnosis, as sensitivity of clinical criteria is significantly lower in ARDS, with a false-negative rate of 46% 2, 4, 9
Even one clinical criterion, unexplained hemodynamic instability, or unexplained deterioration in arterial blood gases should prompt consideration of further diagnostic testing, emphasizing the need for careful monitoring of patients with ARDS 2, 4, 9

The CPIS can be utilized to direct therapy when differentiation between tracheobronchitis and pneumonia is difficult, with a CPIS >6 having 45.8% sensitivity and 60.4% specificity for VAP, although this information is not directly cited, the concept is relevant to the discussion of diagnostic criteria 6, 4

Purulent tracheobronchial secretions are invariably present in patients receiving prolonged mechanical ventilation and are seldom caused by pneumonia, highlighting the need for careful interpretation of clinical criteria 1, 2, 5
Fever, tachycardia, and leukocytosis are nonspecific and can be caused by trauma, surgery, ARDS, deep vein thrombosis, pulmonary embolism, or pulmonary infarction, emphasizing the importance of considering alternative diagnoses 1, 2, 5

Confirm timing: >48 hours after intubation and mechanical ventilation, as recommended by the American College of Chest Physicians 1, 2, 3
Assess for new or progressive radiographic infiltrate on chest X-ray, with the American College of Radiology recommending the use of chest radiographs to confirm the presence of a new infiltrate 1, 2, 6
Count clinical criteria present: temperature abnormality, leukocyte count abnormality, purulent secretions, gas exchange worsening, with the American Thoracic Society recommending the use of at least two clinical criteria to suspect VAP 2, 3, 4
If ≥2 clinical criteria present with infiltrate: suspect VAP and obtain respiratory cultures, with the Infectious Diseases Society of America recommending the use of quantitative or semiquantitative cultures to guide antibiotic therapy 2, 3, 4
If ARDS present: lower threshold to ≥1 clinical criterion or unexplained deterioration, with the American Thoracic Society recommending a lower threshold for diagnosis in patients with ARDS 2, 4, 9
Initiate empiric antibiotics immediately while awaiting culture results, as delayed therapy increases mortality, with the American College of Chest Physicians recommending prompt initiation of therapy 1

The American Thoracic Society recommends obtaining endotracheal aspirates with nonquantitative cultures for initial diagnostic strategy, which is noninvasive and does not require specialized equipment 10
The use of protected specimen brush (PSB) with a threshold of ≥10³ CFU/ml has a sensitivity of 61.4% and specificity of 76.5% for VAP diagnosis 10, 11
Bronchoalveolar lavage (BAL) with a threshold of ≥10⁴ CFU/ml has a sensitivity of 71.1% and specificity of 79.6% for VAP diagnosis 10, 11

Factors increasing the probability of a true-positive result include a colony count >10¹ CFU/ml above threshold, presence of distal purulent secretions, ≥50% neutrophils on BAL differential, and ≥10% neutrophils and ≤1% epithelial cells on direct examination 10
Factors increasing the probability of a true-negative result include a colony count >10¹ CFU/ml below threshold, absence of distal purulent secretions, <50% neutrophils on BAL differential, and <10% neutrophils and >1% epithelial cells on direct examination 10

A CPIS ≤6 at day 3 can guide antibiotic discontinuation, with studies showing 41% of patients with scores of 6 did not have pneumonia by quantitative BAL culture 11

If the patient has not improved after 72 hours of appropriate antibiotic therapy, consider other organisms not covered by the initial regimen, pursue alternative diagnoses, and consider other infectious processes 10, 11
Obtain quantitative cultures if not already done, as clinical failure rarely occurs when protected brush samples recover organisms at <10³ CFU/ml, but higher failure rates occur when cultures exceed 10³ CFU/ml 11